{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:20:59Z","timestamp":1773922859307,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1964,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.seizure.2007.11.020","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T11:03:14Z","timestamp":1200049394000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Bone health in people with epilepsy: Is it impaired and what are the risk factors?"],"prefix":"10.1016","volume":"17","author":[{"given":"Alison","family":"Pack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2007.11.020_bib1","series-title":"Bone health and osteoporosis: a report of the surgeon general","author":"U.S. Department of Health and Human Services","year":"2004"},{"key":"10.1016\/j.seizure.2007.11.020_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-58-6-1003","article-title":"Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment","volume":"58","author":"Weinstein","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.seizure.2007.11.020_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","article-title":"Antiepileptic drug-induced bone loss in young male patients who have seizures","volume":"59","author":"Andress","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2007.11.020_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.20378","article-title":"Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy","volume":"57","author":"Pack","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2007.11.020_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W","article-title":"Increased bone turnover in epileptic patients treated with carbamazepine","volume":"47","author":"Verrotti","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2007.11.020_bib6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1528-1157.2002.13002.x","article-title":"Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine","volume":"43","author":"Verrotti","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.11.020_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","article-title":"Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy","volume":"57","author":"Sato","year":"2001","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2007.11.020_bib8","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.yebeh.2003.11.025","article-title":"Bone health in pediatric epilepsy","volume":"5","author":"Sheth","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2007.11.020_bib9","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.yebeh.2003.11.029","article-title":"Epilepsy and bone health in adults","volume":"5","author":"Pack","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2007.11.020_bib10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/01.wnl.0000180910.72487.18","article-title":"Effect of antiepileptic drug medication on bone mineral measures","volume":"65","author":"Petty","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2007.11.020_bib11","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1212\/01.WNL.0000125185.74276.D2","article-title":"Antiepileptic drug increases rates of bone loss in older women: a prospective study","volume":"62","author":"Ensrud","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2007.11.020_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","article-title":"Epilepsy, osteoporosis, and fracture risk\u2014a meta-analysis","volume":"112","author":"Vestergaard","year":"2005","journal-title":"Acta Neurol Scandanavia"},{"key":"10.1016\/j.seizure.2007.11.020_bib13","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":"Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism","volume":"48","author":"Nissen-Meyer","year":"2007","journal-title":"Epilepsia"},{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2007.11.020_bib14","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.yebeh.2003.11.030","article-title":"Fractures, epilepsy, and antiepileptic drugs","volume":"5","author":"Mattson","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2007.11.020_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s001980170031","article-title":"Identifying bone-mass related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature","volume":"12","author":"Espallargues","year":"2001","journal-title":"Osteopor Int"},{"key":"10.1016\/j.seizure.2007.11.020_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","article-title":"Incidence of fractures among epilepsy patients: a population-based study retrospective cohort study in the General Research Database","volume":"46","author":"Souverein","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.11.020_bib17","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1212\/01.wnl.0000210503.89488.88","article-title":"Use of antiepileptic drugs and risk of fractures: case control study among patients with epilepsy","volume":"66","author":"Souverein","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.020_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","article-title":"A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy","volume":"10","author":"Kim","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.seizure.2007.11.020_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","article-title":"Vitamin D levels and bone turnover in epilepsy taking carbamazepine or oxcarbazepine","volume":"47","author":"Mintzer","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.020_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-3476(95)70304-7","article-title":"Effect of carbamazepine and valproate on bone mineral density","volume":"127","author":"Sheth","year":"1995","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.seizure.2007.11.020_bib21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1528-1157.2001.416800.x","article-title":"Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy","volume":"42","author":"Gou","year":"2001","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2007.11.020_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.5650060406","article-title":"Effect of chronic carbonic anhydrase inhibitor therapy on bone and mineral density in white women","volume":"6","author":"Pierce","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.seizure.2007.11.020_bib23","first-page":"150","article-title":"Effect of topiramate on bone resorption in adults","volume":"2","author":"Leung","year":"2006","journal-title":"Am Epilepsy Soc, Abstr"},{"key":"10.1016\/j.seizure.2007.11.020_bib24","first-page":"211","article-title":"Measurement of bone mineral density in patients on levetiracetam monotherapy","volume":"3","author":"Ali","year":"2006","journal-title":"Am Epilepsy Soc, Abstr"},{"issue":"1","key":"10.1016\/j.seizure.2007.11.020_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","article-title":"Possible involvement or pregnane X receptor-enhanced CYP 24 expression in drug-induced osteomalacia","volume":"115","author":"Pascussi","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.seizure.2007.11.020_bib26","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI27793","article-title":"Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia","volume":"116","author":"Zhou","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.seizure.2007.11.020_bib27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.tiv.2007.02.008","article-title":"Effects of phenytoin and carbamazepine on calcium transport in Caco-2 cells","volume":"21","author":"von Borstel Smith","year":"2007","journal-title":"Toxicol In Vitro"},{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2007.11.020_bib28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yebeh.2003.11.026","article-title":"Pathophysiology of bone loss in patients receiving anticonvulsant therapy","volume":"5","author":"Fitzpatrick","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2007.11.020_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.seizure.2006.10.001","article-title":"Homocysteine and bone loss in epilepsy","volume":"16","author":"Elliott","year":"2007","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.seizure.2007.11.020_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group","volume":"332","author":"Cummings","year":"1995","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.seizure.2007.11.020_bib31","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1528-1167.2006.00507.x","article-title":"Hormone replacement therapy in women with epilepsy: a randomized double-blind, placebo-controlled study","volume":"47","author":"Harden","year":"2006","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2007.11.020_bib32","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/01.wnl.0000247107.54562.0e","article-title":"Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone","volume":"67","author":"Mikati","year":"2006","journal-title":"Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107002385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107002385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:36:31Z","timestamp":1761010591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131107002385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1059131107002385"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2007.11.020","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone health in people with epilepsy: Is it impaired and what are the risk factors?","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2007.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}